Pediatric Immunohematology Clinic, Meir Medical Center, 59 Tchernichovsky St., Kfar Saba, 44281, Israel.
J Clin Immunol. 2011 Aug;31(4):560-6. doi: 10.1007/s10875-011-9537-3. Epub 2011 May 21.
Chronic granulomatous disease (CGD) is an immune deficiency syndrome caused by defects in the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, the enzyme that generates reactive oxygen species (ROS) in phagocytizing leukocytes. This study evaluates the NADPH oxidase capacity in two X-linked CGD patients with mutations in gp91(phox) that alter the regions in this membrane-bound NADPH oxidase component involved in docking of the cytosolic component p47(phox).
Hydrogen peroxide and superoxide generation, bactericidal activity, and NADPH oxidase protein expression by the patients' neutrophils were measured, and genetic analysis was performed.
We report two patients, each with a novel missense mutation in CYBB, the gene that encodes gp91(phox). Surprisingly, neutrophils from these patients showed total absence of superoxide production, although they retained 13-30% of the hydrogen peroxide production capability. We speculate that this is due to direct electron transfer from flavin adenine dinucleotide (FAD) in gp91(phox) to oxygen, leading to inefficient hydrogen peroxide formation instead of efficient superoxide production.
X-linked CGD patients with mutations that alter the gp91(phox) protein in regions involved in docking of the cytosolic NADPH oxidase component p47(phox) may have higher than expected hydrogen peroxide generation capability.
慢性肉芽肿病(CGD)是一种免疫缺陷综合征,由烟酰胺腺嘌呤二核苷酸磷酸(NADPH)氧化酶缺陷引起,该酶在吞噬白细胞中产生活性氧(ROS)。本研究评估了两个 X 连锁 CGD 患者的 NADPH 氧化酶活性,这两个患者的 gp91(phox) 基因突变改变了这个膜结合 NADPH 氧化酶成分中与胞质 NADPH 氧化酶成分 p47(phox) 对接相关的区域。
测量了患者中性粒细胞的过氧化氢和超氧化物生成、杀菌活性和 NADPH 氧化酶蛋白表达,并进行了遗传分析。
我们报告了两名患者,他们的 CYBB 基因(编码 gp91(phox))均发生了新的错义突变。令人惊讶的是,这些患者的中性粒细胞完全缺乏超氧化物生成,尽管它们保留了 13-30%的过氧化氢生成能力。我们推测这是由于 flavin adenine dinucleotide (FAD) 直接从 gp91(phox) 向氧气转移电子,导致过氧化氢形成效率低下而不是超氧化物生成效率低下。
改变 gp91(phox) 蛋白与胞质 NADPH 氧化酶成分 p47(phox) 对接相关区域的 X 连锁 CGD 患者可能具有高于预期的过氧化氢生成能力。